|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2001-10-2
|
|
pubmed:abstractText |
We conducted a multi-center study to investigate the usefulness of a combination drug therapy with doxifluridine (5'-DFUR) and mitomycin C (MMC) in colorectal cancer patients with lung metastasis.
|
|
pubmed:language |
jpn
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0385-0684
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
28
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1263-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11579637-Adult,
pubmed-meshheading:11579637-Aged,
pubmed-meshheading:11579637-Aged, 80 and over,
pubmed-meshheading:11579637-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11579637-Colorectal Neoplasms,
pubmed-meshheading:11579637-Drug Administration Schedule,
pubmed-meshheading:11579637-Female,
pubmed-meshheading:11579637-Floxuridine,
pubmed-meshheading:11579637-Humans,
pubmed-meshheading:11579637-Lung Neoplasms,
pubmed-meshheading:11579637-Male,
pubmed-meshheading:11579637-Middle Aged,
pubmed-meshheading:11579637-Mitomycin,
pubmed-meshheading:11579637-Survival Rate
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
[Combination chemotherapy of doxifluridine plus mitomycin C for colorectal lung metastasis--phase II study].
|
|
pubmed:affiliation |
Gastroenterological Center, Yokohama City University Medical Center.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract,
Multicenter Study
|
